ProQR Therapeutics N.V.

PRQR ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
6-K Sep 23, 2026 FORM 6-K
6-K Sep 9, 2026 FORM 6-K
6-K Aug 13, 2026 6-K
6-K Aug 13, 2026 FORM 6-K
4 Aug 3, 2026 OWNERSHIP DOCUMENT
SCHEDULE 13D/A Jul 29, 2026
SCHEDULE 13G Jul 29, 2026
SCHEDULE 13G/A Jul 24, 2026
4 Jul 21, 2026 OWNERSHIP DOCUMENT
EFFECT Jul 15, 2026
424B5 Jul 15, 2026 424B5
SCHEDULE 13G/A Jul 15, 2026
4 Jul 13, 2026 OWNERSHIP DOCUMENT
4 Jul 8, 2026 OWNERSHIP DOCUMENT
F-3 Jul 6, 2026 F-3
SCHEDULE 13D/A Jun 30, 2026
4/A Jun 30, 2026 OWNERSHIP DOCUMENT
4 Jun 30, 2026 OWNERSHIP DOCUMENT
6-K Jun 26, 2026 FORM 6-K
424B5 Jun 26, 2026 424B5
6-K Jun 25, 2026 FORM 6-K
SCHEDULE 13D/A Jun 3, 2026
4 Jun 3, 2026 OWNERSHIP DOCUMENT
6-K Jun 2, 2026 FORM 6-K
3 Jun 2, 2026 OWNERSHIP DOCUMENT
← Newer Page 1 of 16 · 389 filings Older →